Target Name: LOC105370108
NCBI ID: G105370108
Review Report on LOC105370108 Target / Biomarker Content of Review Report on LOC105370108 Target / Biomarker
LOC105370108
Other Name(s): LOC105370108 variant X1 | uncharacterized LOC105370108 | Uncharacterized LOC105370108, transcript variant X1 | LOC105370108 variant X3 | Uncharacterized LOC105370108, transcript variant X3

LOC105370108: A Drug Target / Disease Biomarker

LOC105370108 is a protein that is expressed in various tissues of the body, including the brain, heart, kidneys, and liver. It is a member of the LOC105 family of proteins, which are known for their role in intracellular signaling. LOC105370108 is of particular interest as a potential drug target or biomarker, due to its involvement in a number of cellular processes that are important for human health and disease.

The LOC105 family of proteins are characterized by the presence of a unique catalytic domain and a variable region that is involved in protein-protein interactions. These proteins are involved in a wide range of cellular processes, including intracellular signaling, DNA replication, and metabolism. The LOC105370108 protein is no exception to these general characteristics.

One of the key functions of LOC105370108 is its role in intracellular signaling. This protein is involved in the regulation of several intracellular signaling pathways, including the TGF-β pathway, the Wnt signaling pathway, and the Hedgehog signaling pathway. These pathways are important for the development, maintenance, and regulation of tissues and organs, and are implicated in a wide range of diseases, including cancer, neurodegenerative diseases, and developmental disorders.

In addition to its role in intracellular signaling, LOC105370108 is also involved in the regulation of cellular processes that are important for tissue growth and development. This protein is involved in the regulation of cell proliferation, cell differentiation, and cell-cell adhesion, and is implicated in the development and maintenance of tissues and organs.

The potential implications of LOC105370108 as a drug target or biomarker are significant. This protein is involved in the regulation of several cellular processes that are important for human health and disease, and may be a useful target for the development of new therapies for a wide range of diseases. For example, LOC105370108 may be a good candidate for the treatment of neurodegenerative diseases, such as Alzheimer's disease, Parkinson's disease, and Huntington's disease, as it is involved in the regulation of the neurotransmitter systems that are affected in these conditions.

LOC105370108 may also be a useful biomarker for the diagnosis and monitoring of certain diseases. For example, LOC105370108 is expressed in several tissues of the body, including the brain, heart, and liver, and may be a useful marker for the diagnosis of certain neurodegenerative diseases, such as Alzheimer's disease. In addition, LOC105370108 may be a useful biomarker for the diagnosis of certain cancers, as it is involved in the regulation of cellular processes that are important for cancer growth and progression.

The identification and characterization of LOC105370108 as a potential drug target or biomarker is an important step in the development of new therapies for a wide range of diseases. Further research is needed to fully understand the role of LOC105370108 in intracellular signaling and cellular processes, and to determine its potential as a drug target or biomarker.

Protein Name: Uncharacterized LOC105370108

The "LOC105370108 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC105370108 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

LOC105370109 | LOC105370113 | LOC105370115 | LOC105370127 | LOC105370128 | LOC105370134 | LOC105370135 | LOC105370165 | LOC105370168 | LOC105370174 | LOC105370176 | LOC105370182 | LOC105370204 | LOC105370214 | LOC105370222 | LOC105370243 | LOC105370259 | LOC105370262 | LOC105370273 | LOC105370275 | LOC105370286 | LOC105370302 | LOC105370311 | LOC105370312 | LOC105370321 | LOC105370324 | LOC105370328 | LOC105370355 | LOC105370359 | LOC105370384 | LOC105370399 | LOC105370420 | LOC105370429 | LOC105370438 | LOC105370452 | LOC105370455 | LOC105370470 | LOC105370476 | LOC105370481 | LOC105370497 | LOC105370500 | LOC105370504 | LOC105370507 | LOC105370519 | LOC105370529 | LOC105370536 | LOC105370544 | LOC105370546 | LOC105370547 | LOC105370548 | LOC105370549 | LOC105370557 | LOC105370572 | LOC105370574 | LOC105370575 | LOC105370577 | LOC105370579 | LOC105370582 | LOC105370614 | LOC105370616 | LOC105370617 | LOC105370619 | LOC105370627 | LOC105370645 | LOC105370660 | LOC105370706 | LOC105370721 | LOC105370740 | LOC105370819 | LOC105370826 | LOC105370832 | LOC105370834 | LOC105370841 | LOC105370842 | LOC105370843 | LOC105370844 | LOC105370845 | LOC105370846 | LOC105370852 | LOC105370878 | LOC105370891 | LOC105370892 | LOC105370905 | LOC105370906 | LOC105370913 | LOC105370914 | LOC105370941 | LOC105370955 | LOC105370965 | LOC105370978 | LOC105370980 | LOC105370982 | LOC105370988 | LOC105370991 | LOC105370995 | LOC105371002 | LOC105371006 | LOC105371060 | LOC105371061 | LOC105371068